Centogene CentoCancer and CentoCard
Centogene has launched CentoCancer and CentoCard. CentoCancer is a 31 gene panel that identifies an elevated risk of significant hereditary cancers including breast, ovarian, gastric, colon, endometrial, prostate, pancreatic, renal, liver, and skin cancer. CentoCard is a sample collection system that can be used to extract high-quality DNA to perform any genetic test, the company said. Once samples are dry, they are considered stable and can be mailed through regular post without special declaration.